Yes, out of all the history of Cudeco on the ASX, three things stand out in my opinion:
The number of lengthy suspensions
The suggestion of quarterly dividends
The share buy back at a massive premium to cash when the company was far from production.
I don't knock WM's efforts to develop Cloncurry. But I wouldn't go to him for corporate finance advice.